1. JAK/STAT Signaling Stem Cell/Wnt Apoptosis Anti-infection
  2. STAT Ferroptosis Parasite Virus Protease
  3. Artesunate

Artesunate is an inhibitor of both STAT-3 and exported protein 1 (EXP1).

For research use only. We do not sell to patients.

Artesunate Chemical Structure

Artesunate Chemical Structure

CAS No. : 88495-63-0

Size Price Stock Quantity
Free Sample (0.1 - 0.5 mg)   Apply Now  
Solid + Solvent (Highly Recommended)
10 mM * 1 mL in DMSO
ready for reconstitution
USD 66 In-stock
Solution
10 mM * 1 mL in DMSO USD 66 In-stock
Solid
50 mg USD 60 In-stock
100 mg USD 96 In-stock
500 mg USD 210 In-stock
1 g USD 370 In-stock
5 g   Get quote  
10 g   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 20 publication(s) in Google Scholar

Other Forms of Artesunate:

Top Publications Citing Use of Products

    Artesunate purchased from MedChemExpress. Usage Cited in: Basic Clin Pharmacol Toxicol. 2022 Nov 26.  [Abstract]

    Artesunate (ART; 1, 2 μM) significantly reduces cell viability in RAW264.7 cells in the presence of RANKL but does not influence undifferentiating cells.
    • Biological Activity

    • Protocol

    • Purity & Documentation

    • References

    • Customer Review

    Description

    Artesunate is an inhibitor of both STAT-3 and exported protein 1 (EXP1).

    IC50 & Target[1][2]

    Stat-3

     

    EXP1

     

    Cellular Effect
    Cell Line Type Value Description References
    A549 IC50
    15.921 μM
    Compound: 1; ART
    Antiproliferative activity against human A549 cells assessed as growth inhibition after 72 hrs by CCK-8 assay
    Antiproliferative activity against human A549 cells assessed as growth inhibition after 72 hrs by CCK-8 assay
    [PMID: 26615886]
    A549 IC50
    5.4 μM
    Compound: 3; ARS
    Cytotoxicity against human A549 cells assessed as reduction in cell viability by MTT assay
    Cytotoxicity against human A549 cells assessed as reduction in cell viability by MTT assay
    [PMID: 33691167]
    A549 IC50
    50.68 μM
    Compound: ATS
    Antiproliferative activity against human A549 cells measured after 48 hrs by MTT assay
    Antiproliferative activity against human A549 cells measured after 48 hrs by MTT assay
    [PMID: 30837097]
    ADR5000 cell line EC50
    0.1 μM
    Compound: 2
    Cytotoxicity against human CEM/ADR5000 cells overexpressing P-gp assessed as reduction in cell viability after 72 hrs by resazurin dye based assay
    Cytotoxicity against human CEM/ADR5000 cells overexpressing P-gp assessed as reduction in cell viability after 72 hrs by resazurin dye based assay
    [PMID: 29937978]
    ADR5000 cell line EC50
    0.189 μM
    Compound: 3
    Cytotoxicity against human CEM/ADR5000 cells over-expressing P-gp assessed as reduction in cell viability after 72 hrs by resazurin dye based assay
    Cytotoxicity against human CEM/ADR5000 cells over-expressing P-gp assessed as reduction in cell viability after 72 hrs by resazurin dye based assay
    [PMID: 29887512]
    ADR5000 cell line IC50
    0.19 μM
    Compound: 3
    Cytotoxicity against human CEM/ADR5000 cells assessed as cell viability after 72 hrs by resazurin assay
    Cytotoxicity against human CEM/ADR5000 cells assessed as cell viability after 72 hrs by resazurin assay
    [PMID: 26260339]
    ADR5000 cell line IC50
    1.2 μM
    Compound: 1
    Cytotoxicity against human CEM/ADR5000 by CCK-8 assay
    Cytotoxicity against human CEM/ADR5000 by CCK-8 assay
    [PMID: 22884578]
    ADR5000 cell line IC50
    1.2 μM
    Compound: 2
    Cytotoxicity against human multidrug-resistant CEM/ADR5000 cells expressing p-glycoprotein by resazurin assay
    Cytotoxicity against human multidrug-resistant CEM/ADR5000 cells expressing p-glycoprotein by resazurin assay
    [PMID: 24561670]
    ADR5000 cell line IC50
    1.2 μM
    Compound: 1
    Cytotoxicity against human CEM/ADR5000 by XTT assay
    Cytotoxicity against human CEM/ADR5000 by XTT assay
    [PMID: 20527917]
    BT-474 IC50
    7.8 μM
    Compound: Artesunate
    Cytotoxicity against human BT474 cells after 48 hrs by MTT assay
    Cytotoxicity against human BT474 cells after 48 hrs by MTT assay
    [PMID: 23790541]
    C-33-A EC50
    1.83 μM
    Compound: 7
    Antiproliferative activity against human C33A cells after 72 hrs by MTT assay
    Antiproliferative activity against human C33A cells after 72 hrs by MTT assay
    [PMID: 30429957]
    CCRF-CEM EC50
    0.069 μM
    Compound: 3
    Cytotoxicity against human CCRF-CEM cells assessed as reduction in cell viability after 72 hrs by resazurin dye based assay
    Cytotoxicity against human CCRF-CEM cells assessed as reduction in cell viability after 72 hrs by resazurin dye based assay
    [PMID: 29887512]
    CCRF-CEM IC50
    0.07 μM
    Compound: 3
    Cytotoxicity against human CCRF-CEM cells assessed as cell viability after 72 hrs by resazurin assay
    Cytotoxicity against human CCRF-CEM cells assessed as cell viability after 72 hrs by resazurin assay
    [PMID: 26260339]
    CCRF-CEM EC50
    0.4 μM
    Compound: 2
    Cytotoxicity against human CCRF-CEM cells assessed as reduction in cell viability after 72 hrs by resazurin dye based assay
    Cytotoxicity against human CCRF-CEM cells assessed as reduction in cell viability after 72 hrs by resazurin dye based assay
    [PMID: 29937978]
    CCRF-CEM IC50
    1.8 μM
    Compound: 1
    Cytotoxicity against human CCRF-CEM cells by CCK-8 assay
    Cytotoxicity against human CCRF-CEM cells by CCK-8 assay
    [PMID: 22884578]
    CCRF-CEM IC50
    1.8 μM
    Compound: 2
    Cytotoxicity against human CCRF-CEM cells by resazurin assay
    Cytotoxicity against human CCRF-CEM cells by resazurin assay
    [PMID: 24561670]
    CCRF-CEM IC50
    1.8 μM
    Compound: 1
    Cytotoxicity against human CCRF-CEM by XTT assay
    Cytotoxicity against human CCRF-CEM by XTT assay
    [PMID: 20527917]
    CHO IC50
    > 100 μM
    Compound: ARS
    Cytotoxicity against CHO cells assessed as reduction in cell viability measured after 48 hrs by MTT assay
    Cytotoxicity against CHO cells assessed as reduction in cell viability measured after 48 hrs by MTT assay
    [PMID: 27448920]
    HCT-116 IC50
    0.89 μM
    Compound: AS
    Antiproliferative activity against human HCT116 cells assessed as inhibition of cell viability after 48 hrs by MTS assay
    Antiproliferative activity against human HCT116 cells assessed as inhibition of cell viability after 48 hrs by MTS assay
    [PMID: 31494469]
    HCT-116 IC50
    7.1 μM
    Compound: Artesunate
    Antiproliferative activity against human HCT-116 cells assessed as growth after 48 hrs by MTT assay
    Antiproliferative activity against human HCT-116 cells assessed as growth after 48 hrs by MTT assay
    [PMID: 27010926]
    HEK293 IC50
    10 μM
    Compound: Artesunate
    Cytotoxicity against HEK293 cells assessed as cell growth inhibition after 72 hrs by Alamar blue assay
    Cytotoxicity against HEK293 cells assessed as cell growth inhibition after 72 hrs by Alamar blue assay
    [PMID: 28774427]
    HEK293 IC50
    2.9 μM
    Compound: artesunate
    Cytotoxicity against human HEK293 cells after 72 hrs by alamar blue assay
    Cytotoxicity against human HEK293 cells after 72 hrs by alamar blue assay
    [PMID: 21155593]
    HEK293 IC50
    7 μM
    Compound: Artesunate
    Cytotoxicity against HEK293 cells after 72 hrs by resazurin dye based assay
    Cytotoxicity against HEK293 cells after 72 hrs by resazurin dye based assay
    [PMID: 29236492]
    HeLa IC50
    0.5 μM
    Compound: Artesunate
    Cytotoxicity against human HeLa cells assessed as cell viability incubated for 48 hrs by MTT assay
    Cytotoxicity against human HeLa cells assessed as cell viability incubated for 48 hrs by MTT assay
    [PMID: 31945642]
    HeLa EC50
    12.03 μM
    Compound: 7
    Antiproliferative activity against human HeLa cells after 72 hrs by MTT assay
    Antiproliferative activity against human HeLa cells after 72 hrs by MTT assay
    [PMID: 30429957]
    HeLa IC50
    19.014 μM
    Compound: 1; ART
    Antiproliferative activity against human HeLa cells assessed as growth inhibition after 72 hrs by CCK-8 assay
    Antiproliferative activity against human HeLa cells assessed as growth inhibition after 72 hrs by CCK-8 assay
    [PMID: 26615886]
    HeLa IC50
    3.2 μM
    Compound: Artesunate
    Cytotoxicity against human HeLa cells incubated for 48 hrs by resazurin dye reduction assay
    Cytotoxicity against human HeLa cells incubated for 48 hrs by resazurin dye reduction assay
    [PMID: 23013253]
    HeLa IC50
    7.1 μM
    Compound: Artesunate
    Antiproliferative activity against human Hela cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
    Antiproliferative activity against human Hela cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
    [PMID: 27010926]
    HepG2 IC50
    < 1 μM
    Compound: Artesunate
    Antimalarial activity against sporozoite stage of Plasmodium yoelii assessed as invasion of human HepG2 cells expressing CD81 incubated for 2 hrs prior to inoculation measured after 1 hr by immunofluorescence assay in presence of penicillin/streptomycin
    Antimalarial activity against sporozoite stage of Plasmodium yoelii assessed as invasion of human HepG2 cells expressing CD81 incubated for 2 hrs prior to inoculation measured after 1 hr by immunofluorescence assay in presence of penicillin/streptomycin
    [PMID: 23927658]
    HepG2 IC50
    12.7 μM
    Compound: artesunate
    Cytotoxicity against human HepG2 cells after 72 hrs by alamar blue assay
    Cytotoxicity against human HepG2 cells after 72 hrs by alamar blue assay
    [PMID: 21155593]
    HepG2 IC50
    20 μM
    Compound: ARS
    Cytotoxicity against human HepG2 cells after 72 hrs by formazan test
    Cytotoxicity against human HepG2 cells after 72 hrs by formazan test
    [PMID: 23685181]
    HepG2 IC50
    22.24 μM
    Compound: 1; ART
    Antiproliferative activity against human HepG2 cells assessed as growth inhibition after 72 hrs by CCK-8 assay
    Antiproliferative activity against human HepG2 cells assessed as growth inhibition after 72 hrs by CCK-8 assay
    [PMID: 26615886]
    HepG2 IC50
    267 μM
    Compound: Artesunate
    Cytotoxicity against human HepG2 cells assessed as cell viability after 72 hrs by MTT assay
    Cytotoxicity against human HepG2 cells assessed as cell viability after 72 hrs by MTT assay
    [PMID: 33158577]
    HepG2 IC50
    39.93 μM
    Compound: ATS
    Antiproliferative activity against human HepG2 cells measured after 48 hrs by MTT assay
    Antiproliferative activity against human HepG2 cells measured after 48 hrs by MTT assay
    [PMID: 30837097]
    HepG2 IC50
    47 μM
    Compound: 3; ARS
    Cytotoxicity against human HepG2 cells assessed as reduction in cell viability by MTT assay
    Cytotoxicity against human HepG2 cells assessed as reduction in cell viability by MTT assay
    [PMID: 33691167]
    HepG2 IC50
    59.4 μM
    Compound: Artesunate
    Antiproliferative activity against human HepG2 cells by MTT assay
    Antiproliferative activity against human HepG2 cells by MTT assay
    [PMID: 31546197]
    HepG2 IC50
    6.5 μM
    Compound: ART
    Dark toxicity against human HepG2 cells assessed as reduction in cell viability incubated overnight by MTT assay
    Dark toxicity against human HepG2 cells assessed as reduction in cell viability incubated overnight by MTT assay
    [PMID: 28882481]
    HepG2 IC50
    7.7 μM
    Compound: ART
    Phototoxicity against human HepG2 cells assessed as reduction in cell viability preincubated overnight followed by irradiation with LED light at 1.7 J/cm'2 for 10 mins measured post overnight incubation by MTT assay
    Phototoxicity against human HepG2 cells assessed as reduction in cell viability preincubated overnight followed by irradiation with LED light at 1.7 J/cm'2 for 10 mins measured post overnight incubation by MTT assay
    [PMID: 28882481]
    HepG2 2.2.15 IC50
    2.3 μM
    Compound: 21
    Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as decrease in HBV surface antigen secretion after 21 days
    Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as decrease in HBV surface antigen secretion after 21 days
    [PMID: 24549242]
    HL-60 IC50
    2 μM
    Compound: ASN
    Cytotoxicity against human HL60 cells assessed as cell viability after 24 hrs by MTT assay
    Cytotoxicity against human HL60 cells assessed as cell viability after 24 hrs by MTT assay
    [PMID: 24148834]
    Huh-7 CC50
    > 100 μg/mL
    Compound: AS
    Cytotoxicity against human Huh-7 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
    Cytotoxicity against human Huh-7 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
    [PMID: 36306538]
    HUVEC IC50
    1.092 μM
    Compound: 1; ART
    Antiproliferative activity against HUVEC assessed as growth inhibition after 72 hrs by CCK-8 assay
    Antiproliferative activity against HUVEC assessed as growth inhibition after 72 hrs by CCK-8 assay
    [PMID: 26615886]
    HUVEC IC50
    86.1 μM
    Compound: 3; ARS
    Cytotoxicity against HUVEC assessed as reduction in cell viability by MTT assay
    Cytotoxicity against HUVEC assessed as reduction in cell viability by MTT assay
    [PMID: 33691167]
    J82 IC50
    75.7 μM
    Compound: 3; ARS
    Cytotoxicity in human J82 cells assessed as reduction in cell viability by MTT assay
    Cytotoxicity in human J82 cells assessed as reduction in cell viability by MTT assay
    [PMID: 33691167]
    K562 IC50
    5.999 μM
    Compound: 1; ART
    Antiproliferative activity against human K562 cells assessed as growth inhibition after 72 hrs by CCK-8 assay
    Antiproliferative activity against human K562 cells assessed as growth inhibition after 72 hrs by CCK-8 assay
    [PMID: 26615886]
    K562/Adr IC50
    6.256 μM
    Compound: 1; ART
    Antiproliferative activity against human K562/ADR cells assessed as growth inhibition after 72 hrs by CCK-8 assay
    Antiproliferative activity against human K562/ADR cells assessed as growth inhibition after 72 hrs by CCK-8 assay
    [PMID: 26615886]
    KB IC50
    78.5 μM
    Compound: Artesunate
    Antiproliferative activity against human KB cells by MTT assay
    Antiproliferative activity against human KB cells by MTT assay
    [PMID: 31546197]
    L02 IC50
    72.17 μM
    Compound: ATS
    Cytotoxicity against human L02 cells measured after 48 hrs by MTT assay
    Cytotoxicity against human L02 cells measured after 48 hrs by MTT assay
    [PMID: 30837097]
    L6 IC50
    1.5 μM
    Compound: Artesunate
    Cytotoxicity against rat L6 cells incubated for 690 hrs by Alamar blue assay
    Cytotoxicity against rat L6 cells incubated for 690 hrs by Alamar blue assay
    [PMID: 23013253]
    L6 IC50
    24 μM
    Compound: AS
    Cytotoxicity against rat L6 cells after 72 hrs by alamar blue assay
    Cytotoxicity against rat L6 cells after 72 hrs by alamar blue assay
    [PMID: 25195945]
    L6 IC50
    6.63 μM
    Compound: 2
    Cytotoxicity in rat L6 cells assessed as reduction in cell viability incubated for 72 hrs by alamar blue dye based assay
    Cytotoxicity in rat L6 cells assessed as reduction in cell viability incubated for 72 hrs by alamar blue dye based assay
    [PMID: 28988153]
    LS174T IC50
    10 μM
    Compound: ARS
    Cytotoxicity against human LS 174T cells after 72 hrs by formazan test
    Cytotoxicity against human LS 174T cells after 72 hrs by formazan test
    [PMID: 23685181]
    MCF-10A IC50
    21 μM
    Compound: Artesunate
    Cytotoxicity against human MCF10A cells after 48 hrs by MTT assay
    Cytotoxicity against human MCF10A cells after 48 hrs by MTT assay
    [PMID: 23790541]
    MCF7 IC50
    38.71 μM
    Compound: ATS
    Antiproliferative activity against human MCF7 cells measured after 48 hrs by MTT assay
    Antiproliferative activity against human MCF7 cells measured after 48 hrs by MTT assay
    [PMID: 30837097]
    MCF7 EC50
    4.21 μM
    Compound: 7
    Antiproliferative activity against human MCF7 cells after 72 hrs by MTT assay
    Antiproliferative activity against human MCF7 cells after 72 hrs by MTT assay
    [PMID: 30429957]
    MDA-MB-231 EC50
    10.04 μM
    Compound: 7
    Antiproliferative activity against human MDA-MB-231 cells after 72 hrs by MTT assay
    Antiproliferative activity against human MDA-MB-231 cells after 72 hrs by MTT assay
    [PMID: 30429957]
    MDA-MB-231 IC50
    46 μM
    Compound: Artesunate
    Cytotoxicity against human MDA-MB-231 cells after 48 hrs by MTT assay
    Cytotoxicity against human MDA-MB-231 cells after 48 hrs by MTT assay
    [PMID: 23790541]
    MDA-MB-231 IC50
    75.69 μM
    Compound: ATS
    Antiproliferative activity against human MDA-MB-231 cells measured after 48 hrs by MTT assay
    Antiproliferative activity against human MDA-MB-231 cells measured after 48 hrs by MTT assay
    [PMID: 30837097]
    MDA-MB-361 EC50
    2.27 μM
    Compound: 7
    Antiproliferative activity against human MDA-MB-361 cells after 72 hrs by MTT assay
    Antiproliferative activity against human MDA-MB-361 cells after 72 hrs by MTT assay
    [PMID: 30429957]
    MRC5 IC50
    6.8 μM
    Compound: Artesunate
    Cytotoxicity against human MRC5 cells incubated for 48 hrs by resazurin dye reduction assay
    Cytotoxicity against human MRC5 cells incubated for 48 hrs by resazurin dye reduction assay
    [PMID: 23013253]
    OVCAR-3 IC50
    67.3 μM
    Compound: 3; ARS
    Cytotoxicity against human OVCAR3 cells assessed as reduction in cell viability by MTT assay
    Cytotoxicity against human OVCAR3 cells assessed as reduction in cell viability by MTT assay
    [PMID: 33691167]
    SiHa EC50
    > 30 μM
    Compound: 7
    Antiproliferative activity against human SiHa cells after 72 hrs by MTT assay
    Antiproliferative activity against human SiHa cells after 72 hrs by MTT assay
    [PMID: 30429957]
    SK-HEP1 IC50
    10 μM
    Compound: ARS
    Cytotoxicity against human SKHEP1 cells after 72 hrs by formazan test
    Cytotoxicity against human SKHEP1 cells after 72 hrs by formazan test
    [PMID: 23685181]
    SMMC-7721 IC50
    72.3 μM
    Compound: 3; ARS
    Cytotoxicity against human SMMC-7721 cells assessed as reduction in cell viability by MTT assay
    Cytotoxicity against human SMMC-7721 cells assessed as reduction in cell viability by MTT assay
    [PMID: 33691167]
    T47D EC50
    2.22 μM
    Compound: 7
    Antiproliferative activity against human T47D cells after 72 hrs by MTT assay
    Antiproliferative activity against human T47D cells after 72 hrs by MTT assay
    [PMID: 30429957]
    WI-38 IC50
    > 100 μM
    Compound: ARS
    Cytotoxicity against human WI38 cells assessed as reduction in cell viability measured after 48 hrs by SRB assay
    Cytotoxicity against human WI38 cells assessed as reduction in cell viability measured after 48 hrs by SRB assay
    [PMID: 27448920]
    WI-38 IC50
    > 100 μM
    Compound: Artesunate
    Cytotoxicity against human WI38 cells assessed as growth inhibition after 48 hrs by sulforhodamine B assay
    Cytotoxicity against human WI38 cells assessed as growth inhibition after 48 hrs by sulforhodamine B assay
    [PMID: 27210430]
    WM 266-4 IC50
    8.46 μM
    Compound: AS
    Antiproliferative activity against human WM266.4 cells assessed as inhibition of cell viability after 48 hrs by MTS assay
    Antiproliferative activity against human WM266.4 cells assessed as inhibition of cell viability after 48 hrs by MTS assay
    [PMID: 31494469]
    In Vitro

    Artesunate is an inhibitor of both STAT-3[1] and exported protein 1 (EXP1)[2]. Artesunate treatment for 24 h causes a significant increase in the levels of reactive oxygen species (ROS) in a dose-dependent manner in both cell lines. Moreover, Western blotting shows that the levels ofγ-H2AX are significantly elevated when cancer cells are treated with Artesunate in the higher dose range for 24 h. Artesunate also shows a time-dependent effect on the level of RAD51 in A2780 and HO8910 cells. In two types of non-malignant cells, normal human fibroblasts and immortalized epithelial cells, FTE-187, the level of RAD51 is not altered by Artesunate. In A2780 cells, the level of RAD51 mRNA is indeed decreased by the addition of Artesunate, in a dose-dependent manner. Correspondingly, the promoter activity of RAD51 is significantly inhibited by Artesunate. In contrast, the RAD51 mRNA level in H8910 cells is not affected by Artesunate[3].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    In Vivo

    Tumor growth is significantly reduced in the group receiving combined treatment of Artesunate and cisplatin (P<0.01). In comparison, Artesunate alone has no significant effect on the growth of tumor xenografts for both cell lines[3].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    Clinical Trial
    Molecular Weight

    384.42

    Formula

    C19H28O8

    CAS No.
    Appearance

    Solid

    Color

    White to off-white

    SMILES

    O=C(O[C@H]1[C@H](C)[C@]2([H])CC[C@@H](C)[C@]3([H])CC[C@@](O4)(C)OO[C@]32[C@]4([H])O1)CCC(O)=O

    Structure Classification
    Initial Source
    Shipping

    Room temperature in continental US; may vary elsewhere.

    Storage
    Powder -20°C 3 years
    4°C 2 years
    In solvent -80°C 6 months
    -20°C 1 month
    Solvent & Solubility
    In Vitro: 

    DMSO : 83.33 mg/mL (216.77 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

    7.5% Sodium bicarbonate : 2 mg/mL (5.20 mM; ultrasonic and warming and heat to 60°C)

    H2O : < 0.1 mg/mL (insoluble)

    Preparing
    Stock Solutions
    Concentration Solvent Mass 1 mg 5 mg 10 mg
    1 mM 2.6013 mL 13.0066 mL 26.0132 mL
    5 mM 0.5203 mL 2.6013 mL 5.2026 mL
    View the Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

    • Molarity Calculator

    • Dilution Calculator

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    Mass
    =
    Concentration
    ×
    Volume
    ×
    Molecular Weight *

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    This equation is commonly abbreviated as: C1V1 = C2V2

    Concentration (start)

    C1

    ×
    Volume (start)

    V1

    =
    Concentration (final)

    C2

    ×
    Volume (final)

    V2

    In Vivo:

    Select the appropriate dissolution method based on your experimental animal and administration route.

    For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
    To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for in vivo experiments, it is recommended to prepare freshly and use it on the same day.
    The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

    • Protocol 1

      Add each solvent one by one:  10% DMSO    40% PEG300    5% Tween-80    45% Saline

      Solubility: ≥ 2.08 mg/mL (5.41 mM); Clear solution

      This protocol yields a clear solution of ≥ 2.08 mg/mL (saturation unknown).

      Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (20.8 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.

      Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
    • Protocol 2

      Add each solvent one by one:  10% DMSO    90% (20% SBE-β-CD in Saline)

      Solubility: ≥ 2.08 mg/mL (5.41 mM); Clear solution

      This protocol yields a clear solution of ≥ 2.08 mg/mL (saturation unknown).

      Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (20.8 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.

      Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
    In Vivo Dissolution Calculator
    Please enter the basic information of animal experiments:

    Dosage

    mg/kg

    Animal weight
    (per animal)

    g

    Dosing volume
    (per animal)

    μL

    Number of animals

    Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
    Please enter your animal formula composition:
    %
    DMSO +
    +
    %
    Tween-80 +
    %
    Saline
    Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
    The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
    Calculation results:
    Working solution concentration: mg/mL
    Method for preparing stock solution: mg drug dissolved in μL  DMSO (Stock solution concentration: mg/mL).
    The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only. If necessary, please contact MedChemExpress (MCE).
    Method for preparing in vivo working solution for animal experiments: Take μL DMSO stock solution, add μL . μL , mix evenly, next add μL Tween 80, mix evenly, then add μL Saline.
     If the continuous dosing period exceeds half a month, please choose this protocol carefully.
    Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
    Purity & Documentation

    Purity: 99.84%

    References
    Kinase Assay
    [3]

    After treatment with Artesunate for 24 h, cells are harvested and lysed in 1×cell lysis buffer. Total proteins of 15 to 25 μg are separated by SDS-PAGE and transferred to polyvinylidenedifluoride (PVDF) membranes. Membranes are blocked with 5% non-fat milk for 1 to 2 h at room temperature and then probed with primary antibodies and incubated at 4°C overnight. After extensive washing with TBS-T, membranes are incubated with appropriate HRP-conjugated secondary antibody for 1 h at room temperature, and then are detected by Western ECL-enhanced luminol reagent [3].

    MCE has not independently confirmed the accuracy of these methods. They are for reference only.

    Cell Assay
    [3]

    A2780 and HO8910 cells are cultured in RPMI 1640, Normal human fibroblasts (NHF) in DMEM, and FTE-187 in M199, supplemented with 10% fetal bovine serum, 100 units/mL penicillin, and 100 mg/mL streptomycin. All the cells are incubated in a humidified atmosphere of 95% air and 5% CO2. Artesunate is applied to the cultured cells at the concentration of 0, 5, 10, 25, or 50 µg/mL for various periods. The reactive oxygen species (ROS) production following Artesunate treatment is determined. Briefly, cells are loaded with 5 μM of CM-H2DCFDA and incubated at 37°C for 20 min after treatment with Artesunate. Cells are resuspended using preserving fluid and analyzed with a FACSCanto II. The peak excitation wavelength for oxidized CM-H2DCFDA is 490 nm and emission is 530 nm[3].

    MCE has not independently confirmed the accuracy of these methods. They are for reference only.

    Animal Administration
    [3]

    Four to six weeks old female athymic nude mice (BALB/c, nu/nu) are used. A2780 and HO8910 cells are harvested and resuspended in 0.1 ml of PBS, 5×106 cells/0.2 mL are injected subcutaneously into the left inguinal area of the mice. Two weeks later, mice bearing tumors (~70 mm3 for A2780 and HO8910) are randomly divided into 4 groups. Artesunate is administered daily via i.p. injection at doses of 50 mg/kg alone for 16 days. The tumor growth is monitored every other day. Tumor volume is determined by the formula 1/2a×b2 where a is the long diameter (mm) and b is the short diameter (mm)[3].

    MCE has not independently confirmed the accuracy of these methods. They are for reference only.

    References

    Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

    Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
    7.5% Sodium bicarbonate / DMSO 1 mM 2.6013 mL 13.0066 mL 26.0132 mL 65.0330 mL
    5 mM 0.5203 mL 2.6013 mL 5.2026 mL 13.0066 mL
    DMSO 10 mM 0.2601 mL 1.3007 mL 2.6013 mL 6.5033 mL
    15 mM 0.1734 mL 0.8671 mL 1.7342 mL 4.3355 mL
    20 mM 0.1301 mL 0.6503 mL 1.3007 mL 3.2517 mL
    25 mM 0.1041 mL 0.5203 mL 1.0405 mL 2.6013 mL
    30 mM 0.0867 mL 0.4336 mL 0.8671 mL 2.1678 mL
    40 mM 0.0650 mL 0.3252 mL 0.6503 mL 1.6258 mL
    50 mM 0.0520 mL 0.2601 mL 0.5203 mL 1.3007 mL
    60 mM 0.0434 mL 0.2168 mL 0.4336 mL 1.0839 mL
    80 mM 0.0325 mL 0.1626 mL 0.3252 mL 0.8129 mL
    100 mM 0.0260 mL 0.1301 mL 0.2601 mL 0.6503 mL
    • No file chosen (Maximum size is: 1024 Kb)
    • If you have published this work, please enter the PubMed ID.
    • Your name will appear on the site.
    Help & FAQs
    • Do most proteins show cross-species activity?

      Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

    Your Recently Viewed Products:

    Inquiry Online

    Your information is safe with us. * Required Fields.

    Product Name

     

    Salutation

    Applicant Name *

     

    Email Address *

    Phone Number *

     

    Organization Name *

    Department *

     

    Requested quantity *

    Country or Region *

         

    Remarks

    Bulk Inquiry

    Inquiry Information

    Product Name:
    Artesunate
    Cat. No.:
    HY-N0193
    Quantity:
    MCE Japan Authorized Agent: